Back to Newsroom
Back to Newsroom

SLQT, ANVS & VIEW - Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Actions and Deadlines

Monday, 20 September 2021 11:00 AM

Bronstein, Gewirtz and Grossman, LLC

Topic:
Lawsuits

NEW YORK, NY / ACCESSWIRE / September 20, 2021 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss, you can request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. A lead plaintiff acts on behalf of all other class members in directing the litigation. The lead plaintiff can select a law firm of its choice. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Bronstein, Gewirtz and Grossman, LLC, Monday, September 20, 2021, Press release picture

SelectQuote, Inc. (NYSE:SLQT)
Class Period: February 8, 2021 - May 11, 2021
Deadline: October 15, 2021
For more info: www.bgandg.com/slqt.

The complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose: (1) that SelectQuote's 2019 cohort was underperforming; (2) that, as a result, the Company's financial results would be adversely impacted; and (3) that, as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Annovis Bio, Inc. (NYSE:ANVS)
Class Period: May 21, 2021 - July 28, 2021
Deadline: October 18, 2021
For more info: www.bgandg.com/anvs.

The complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose: (1) that Annovis's ANVS401 did not show statistically significant results across two patient populations as to factors such as orientation, judgement, and problem solving; and (2) as a result, Defendants' statements about its business, operations, and prospects were materially false and misleading and/or lacked reasonable basis at all relevant times.

View, Inc. (NASDAQ:VIEW)
Class Period: November 30, 2020 - August 16, 2021
Deadline: October 18, 2021
For more info: www.bgandg.com/view.

The complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose: (1) that View had not properly accrued warranty costs related to its product; (2) that there was a material weakness in View's internal controls over accounting and financial reporting related to warranty accrual; (3) that, as a result, the Company's financial results for prior periods were misstated; and (4) as a result, Defendants' statements about its business, operations, and prospects were materially false and misleading and/or lacked reasonable basis at all relevant times.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Nathanson
212-697-6484 | [email protected]

SOURCE: Bronstein, Gewirtz & Grossman, LLC

Topic:
Lawsuits
Back to newsroom
Back to Newsroom
Share by: